Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trial
Objectives: To identify the lowest dose of Depo-Provera that, when administered off-label subcutaneously, suppressed ovulation and had a pharmacokinetic profile consistent with a 4-month contraceptive effect.Study Design: We conducted a randomized, multicenter, parallel-group study to evaluate the p...
Saved in:
Main Authors: | Vera Halpern (Author), Rachael Fuchs (Author), Vivian Brache (Author), Luis Bahamondes (Author), Maria Jose Miranda (Author), Anja Lendvay (Author), Leila Cochón (Author), Douglas Taylor (Author), Laneta J. Dorflinger (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
by: Douglas J. Taylor, et al.
Published: (2022) -
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation
by: Vera Halpern, et al.
Published: (2023) -
Return to ovulation after Sayana Press is injected every 4 months for one year: Empirical and pharmacokinetic/pharmacodynamic modeling results
by: Douglas J. Taylor, et al.
Published: (2022) -
Incidental Finding of Persistent Hydatidiform Mole in an Adolescent on Depo-Provera
by: Olukayode Akinlaja, et al.
Published: (2016) -
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
by: Lam C, et al.
Published: (2016)